Fennec Pharmaceuticals Inc. Common StockFENC
Scheduled
Fennec Pharmaceuticals Inc. Common Stock H.C. Wainwright 28th Annual Global Investment Conference
Review the key takeaways and the transcript of this earnings call.
PeriodFY 0
Key takeaways
- Fennec has one product, PEDMARC, which was approved in September of 2022.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Keep exploring